Surgical Specialties to Distribute Ortho-ATI in Australia, New Zealand

Orthocell appointed Surgical Specialties as exclusive distributor in Australia and New Zealand for Ortho-ATI® (Autologous Tenocyte Injection) and Ortho-ACI® (Autologous Chondrocyte Implantation) cell therapies for tendon and cartilage regeneration, respectively. The five-year agreement allows Orthocell to focus resources...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us